26
Views
38
CrossRef citations to date
0
Altmetric
Original Article

Development of phenytoin-induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs

&
Pages 81-85 | Received 28 Jul 1986, Published online: 02 Jul 2009

References

  • Klar L A. Gingival hyperplasia during dilantin therapy; a survey of 312 patients. J Public Health Dent 1973; 33: 180–5
  • Londberg B. Born med epilepsi som patienter i den systematiske bornetandpleje. Tandlaegebhdet 1973; 77: 46–58
  • Modéer T, Dahllöf G, Theorell K. Oral health in non-institutionalized epileptic children with special reference to phenytoin medication. Comra Dent Oral Epidemiol 1986; 14: 165–8
  • Dahllöf G, Modfier T. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A two-year longitudinal study. J Clin Periodontol 1986; 13: 845–9
  • Nuki K, Cooper S H. The role of inflammation in the pathogenesis of gingival enlargement during the administration of diphenylhydantoin sodium in cats. J Periodont Res 1972; 7: 102–10
  • Ciancio S G, Yaffe S J, Catz C C. Gingival hyperplasia and diphenylhydantoin. J Periodontol 1972; 43: 41H
  • Donnenfeldt O W, Stanley H R, Bagdonoff L. A nine months clinical and histological study of patients on diphenylhydantoin following gingi-vectomy. J Periodontol 1974; 45: 547–57
  • King D A, Hawes R R, Bibby B G. The effect of oral physiotherapy on dilantin gingival hyperplasia. J Oral Pathol 1976; 5: 1–7
  • Hassell T M. Epilepsy and the oral manifestations of phenytoin therapy. Karger, Basel 1981
  • Pihlstrom B L, Carlson J F, Smith Q T, Bastain S A, Keenan K M. Prevention of phenytoin associated gingival enlargement. A 15-month longitudinal study. J Periodontol 1980; 51: 311–7
  • Axelsson P, Lindhe J. Effect of controlled oral hygiene on caries and periodontal disease in adults. J Clin Periodontol 1978; 5: 133–40
  • Lundström A. Tooth size and occlusion in twins [Thesis]. Karger, Stockholm 1948
  • Lu-Steffes M, Pittluck G W, Jolley M E, Panas H N, Olive D L, Wang C-HJ, Nystrom D D. Keegan CL, Davis TP, Stroupe SD. Fluorescence polarization immunoassay. Determination of phenytoin and phenobarbital in human serum and plasma. Clin Chem 1982; 28: 2278–82
  • Lundström Å, Eeg-Olofsson O, Hamp S-E. Effects of anti-epileptic drug treatment with carbamazepine or phenytoin on the oral state of children and adolescents. J Clin Periodontol 1982; 9: 482–8
  • Aas E. Hyperplasia gingivae diphenylhydantoinea. Acta Odontol Scand 1963; 21: 1–132, suppl 34
  • Angelopoulos A P, Goaz P W. Incidence of diphenylhydantoin gingival hyperplasi. Oral Surg 1972; 34: 898–906
  • Hassell T, O'Donnell J, Pearlman J, Tesini D, Murphy T, Best H. Phenytoin induced gingival overgrowth in institutionalized epileptics. J Clin Periodontol 1984; 11: 242–53
  • Gupta C, Katsumata M, Goldman A S. H-2 histocompatibility region influences the inhibition of arachidonic acid cascade by dexamethasone and phenytoin in mouse embryonic palates. J Craniofac Gen Develop Biol 1985; 5: 277–85
  • Seymour R A, Smith D G, Turnbull D N. The effects of phenytoin and sodium valproate on the periodontal health of adult epileptic patients. J Clin Periodontol 1985; 12: 413–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.